Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia
Patients with X-linked agammaglobulinemia (XLA) have failure of B-cell development with lack of immunoglobulin (Ig) production. While immunoglobulin replacement therapy (IgRT) is beneficial, XLA patients remain at risk for infections, structural lung damage, and rarely, neoplasia. Allogeneic stem ce...
Main Authors: | Menno C. van Zelm, Marsus Pumar, Peter Shuttleworth, Pei M. Aui, Joanne M. Smart, Andrew Grigg, Julian J. Bosco |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00895/full |
Similar Items
-
Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells
by: Emily S. J. Edwards, et al.
Published: (2019-11-01) -
Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling
by: Jacques G. Rivière, et al.
Published: (2020-02-01) -
Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia
by: Chai Teng Chear, et al.
Published: (2023-09-01) -
Identification of a novel BTK variant in a Chinese family with X-linked agammaglobulinemia
by: ZHANG Han, SUN Yang, WANG Rong-rong, ZHANG Wen, ZHANG Xue
Published: (2021-04-01) -
Clinical and genetic findings in two siblings with X-Linked agammaglobulinemia and bronchiolitis obliterans: a case report
by: Ronaldo da Silva Francisco Junior, et al.
Published: (2022-04-01)